This inventor holds 1 USPTO granted patent. Top assignee: Yasutoshi Muto. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Yasutoshi Muto: Innovator in Anticarcinogenic Drug Composition
Introduction
Yasutoshi Muto is a notable inventor based in Gifu, Japan. He has made significant contributions to the field of medicine, particularly in the development of anticarcinogenic drug compositions. His work focuses on addressing critical health issues, including various forms of cancer.
Latest Patents
Muto holds a patent for an anticarcinogenic drug composition that effectively inhibits the recurrence of hepatocellular carcinoma and other types of cancer. This innovative composition is designed to be highly safe and contains 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid or a salt thereof. His patent represents a significant advancement in cancer treatment, particularly for high-risk groups.
Career Highlights
Throughout his career, Yasutoshi Muto has demonstrated a commitment to improving cancer treatment options. His research has led to the development of a drug composition that not only targets the recurrence of cancer but also aims to prevent the occurrence of new tumors in patients with chronic conditions.
Collaborations
Muto has collaborated with esteemed colleagues such as Hisataka Moriwaki and Mitsuo Ninomiya. These partnerships have contributed to the advancement of his research and the successful development of his patented drug composition.
Conclusion
Yasutoshi Muto's contributions to the field of medicine through his innovative anticarcinogenic drug composition highlight his dedication to combating cancer. His work continues to inspire advancements in cancer treatment and offers hope to many patients.